CROMAZOL Trademark

Trademark Overview

On Tuesday, February 13, 2024, a trademark application was filed for CROMAZOL with the United States Patent and Trademark Office. The USPTO has given the CROMAZOL trademark a serial number of 98404290. The federal status of this trademark filing is FIRST EXTENSION - GRANTED as of Tuesday, April 14, 2026. This trademark is owned by Samdolite Pharmaceuticals. The CROMAZOL trademark is filed in the Pharmaceutical Products category with the following description:

Dermatological pharmaceutical products; pharmaceutical preparations for treating skin disorders; pharmaceutical preparations for use in dermatology; medicated topical skin care formulations
cromazol

General Information

Serial Number98404290
Word MarkCROMAZOL
Filing DateTuesday, February 13, 2024
Status730 - FIRST EXTENSION - GRANTED
Status DateTuesday, April 14, 2026
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 19, 2025

Trademark Statements

Goods and ServicesDermatological pharmaceutical products; pharmaceutical preparations for treating skin disorders; pharmaceutical preparations for use in dermatology; medicated topical skin care formulations

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, March 18, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameSamdolite Pharmaceuticals
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSaint Charles, MO 63304
US
Party NameSamdolite Pharmaceuticals
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSaint Charles, MO 63304
US

Trademark Events

Event DateEvent Description
Friday, February 16, 2024NEW APPLICATION ENTERED
Monday, March 18, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, May 31, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, May 31, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, May 31, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, September 5, 2024ASSIGNED TO EXAMINER
Monday, September 9, 2024NON-FINAL ACTION WRITTEN
Monday, September 9, 2024NON-FINAL ACTION E-MAILED
Monday, September 9, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, September 25, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, September 25, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, September 25, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, October 15, 2024NON-FINAL ACTION WRITTEN
Tuesday, October 15, 2024NON-FINAL ACTION E-MAILED
Tuesday, October 15, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, December 9, 2024LETTER OF PROTEST EVIDENCE FORWARDED
Monday, December 9, 2024LETTER OF PROTEST EVIDENCE REVIEWED-NO FURTHER ACTION TAKEN
Friday, January 3, 2025TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, January 3, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, January 3, 2025TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, February 6, 2025NON-FINAL ACTION WRITTEN
Thursday, February 6, 2025NON-FINAL ACTION E-MAILED
Thursday, February 6, 2025NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, April 28, 2025TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, May 6, 2025ASSIGNED TO LIE
Tuesday, May 6, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, May 6, 2025TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, July 10, 2025APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, August 13, 2025NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, August 19, 2025PUBLISHED FOR OPPOSITION
Tuesday, August 19, 2025OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 14, 2025NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, April 14, 2026SOU TEAS EXTENSION RECEIVED
Tuesday, April 14, 2026SOU EXTENSION 1 FILED
Tuesday, April 14, 2026SOU EXTENSION 1 GRANTED
Wednesday, April 15, 2026NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Related Keywords

cromazol pharmaceutical preparations skin topical care formulations medicated dermatology treating dermatological